NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 ORTIN GLOBAL LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 (Quarter ended 30.06.2026): Net loss of ₹33.79 crore after tax • Net Sales/ | 2026-08-14 |
| Quarterly results | 2026-07-09 |
| Quarterly results · Q4 FY26 ORTIN GLOBAL LIMITED - DOCUMENT SUMMARY HEADLINE NUMBERS • Board meeting held on 30.05.2026 approved audited financial results for Q4 FY2026 (quarte | 2026-05-30 |
| Quarterly results · Q3 FY26 ORTIN GLOBAL LIMITED - FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 FY2025-26 (Quarter ended 31.12.2025): Net loss of Rs 5.32 lakhs • 9-Month Period (Apr | 2026-02-14 |
| Annual report FY2025 ORTIN GLOBAL LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Company: Ortin Global Limited (formerly Ortin Laboratories Limited) • CIN: L68200TG1986PL | 2025-09-08 |
| Quarterly results · Q1 FY26 ORTIN GLOBAL LIMITED – FINANCIAL SUMMARY (Q1 FY2025-26) HEADLINE NUMBERS • Quarter Ended 30.06.2025 (Unaudited): - Net Sales/Operating Income: Rs | 2025-08-14 |
| Quarterly results | 2025-02-12 |
| Quarterly results | 2024-11-13 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Ortin Global Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.